microRNA: emerging therapeutic targets in acute ischemic diseases.
about
MicroRNA-210: a unique and pleiotropic hypoxamirTissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaThe role of microRNAs in human liver cancersOxymiRs in cutaneous development, wound repair and regenerationmiR-127 protects proximal tubule cells against ischemia/reperfusion: identification of kinesin family member 3B as miR-127 targetDeregulated microRNAs in myotonic dystrophy type 2Integrating multi-platform genomic data using hierarchical Bayesian relevance vector machinesEpigenetics: an expanding new piece of the stroke puzzleEmerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic AgentsMicroRNAs expression profiles in cardiovascular diseases.HypoxamiR regulation and function in ischemic cardiovascular diseases.Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia.Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs.MicroRNA modulate alveolar epithelial response to cyclic stretch.miRNA signature of unfolded protein response in H9c2 rat cardiomyoblasts.ROD1 is a seedless target gene of hypoxia-induced miR-210.Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approachMicroRNAs in skin and wound healing.Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs.Differential expression of microRNAs in ischemic heart disease.MicroRNAs modulated by local mIGF-1 expression in mdx dystrophic mice.MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRFACVR1, a therapeutic target of fibrodysplasia ossificans progressiva, is negatively regulated by miR-148a.Next generation sequencing for profiling expression of miRNAs: technical progress and applications in drug developmentHuman circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction.The evolving roles of pericyte in early brain injury after subarachnoid hemorrhage.Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia.Identification and Functional Analysis of MicroRNAs in Mice following Focal Cerebral Ischemia InjuryEpigenetic mechanisms in stroke and epilepsy.Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.Emerging molecular targets for brain repair after strokeGlobal remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathwayThe altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury.Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts.miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTENMicroRNAs as effectors of brain function.Assessing Agreement between miRNA Microarray PlatformsBone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.MiR-499-5p protects cardiomyocytes against ischaemic injury via anti-apoptosis by targeting PDCD4.Cell biology of ischemia/reperfusion injury.
P2860
Q24601095-03746A30-82D7-4C9A-87BD-52909D8880D4Q26743361-3ADA5FAC-C2BE-4E81-981E-6F3D2A7A6703Q26861699-D10E24EF-A1A1-4D7A-B674-5FF6165C6921Q27024906-7C196D6A-B405-4ACE-91BE-509924F36B8AQ27320810-C07F8086-FBED-44AB-9EA0-CF43743BC0E2Q28727681-8C50DDA0-C121-4EEC-ABBC-05B724988FBEQ30652069-FD728679-EF37-4F21-8458-704A4907C703Q33352309-E270C4EE-13B8-4A6E-BE7A-6FB90E54FAAAQ33783563-45A387ED-781F-45A8-8AB6-030E370B63BEQ33821302-6E4530EA-7C99-4DD2-975F-DAE8352DADF9Q34082010-428409FF-E8DB-414D-947F-D2A582E42FEAQ34082176-A8D8E3F2-ADB7-48C6-BE6B-16EF8D75F29DQ34142769-9DBBD8EE-F592-47A9-BBA6-66B851AEA420Q34248325-3E1BC9D4-2354-4572-9D7A-037581D91D6EQ34309435-90C5F705-2236-4315-A9D8-FB05F0DBD766Q34425017-F114AC5C-9216-4D8A-9437-70961EE932A6Q34545716-AD55B5B2-CE16-4D26-B8C2-3A2B3D61EF52Q35033659-C19C1902-DF04-43AE-82B4-EB94538A2D25Q35087731-1A5933ED-00EB-4D1C-A351-86B7D7E26499Q35108100-748A6FA4-2FEE-4CCE-A4F2-3D792BED27C6Q35569587-6A0E3ABC-12D1-4AFB-A861-A4C6A02F039DQ35571915-3ECAA05F-EA97-41B3-8A78-A86F52AAE717Q35795849-039FB91D-9D41-4C63-8ABE-11D01FCDB52EQ35854108-5E4AE039-2EAB-40EB-825D-F15A5BB33FB2Q36025533-07FDD593-572D-4838-B6FA-49EE1C682A3DQ36058921-884FB28C-4127-4E5A-AF4A-D2E56A199353Q36185344-66B7AA4A-2A87-4D7E-8941-47DA0D3CC711Q36247404-131A2162-E5F8-4826-8CC8-8715674F8D95Q36465823-9A2D1DDC-3F2F-41DF-B3D3-78F5AD9E0103Q36503183-37FD0452-AD01-440B-9E00-8E15FFD0D6F8Q36567408-9956EAD4-349B-453A-9ED9-89061D5596CCQ36739740-8966706B-155A-48A4-AE05-D4B8E8A557DDQ36959913-D7A6F2DF-E649-43B1-9E99-EB30CA156A9EQ36965488-7F98AD96-00B6-4EAF-838E-68491C17947FQ36998116-81AB8E6C-24D5-4316-ADEF-CC77B5C4EB06Q37088938-F2711CD7-F7B0-47E4-834B-0069463778C7Q37163423-67F0CE27-1B85-4802-B5C0-A1BE0C63DEAFQ37294594-7E81E348-9DA9-4A57-9368-1FA12FB50AC7Q37392535-C4DC2D05-58EF-4B62-82BA-C76D6DA18DE3Q37524901-96F19D27-6F31-47BD-B357-358299E816EC
P2860
microRNA: emerging therapeutic targets in acute ischemic diseases.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
microRNA: emerging therapeutic targets in acute ischemic diseases.
@ast
microRNA: emerging therapeutic targets in acute ischemic diseases.
@en
type
label
microRNA: emerging therapeutic targets in acute ischemic diseases.
@ast
microRNA: emerging therapeutic targets in acute ischemic diseases.
@en
prefLabel
microRNA: emerging therapeutic targets in acute ischemic diseases.
@ast
microRNA: emerging therapeutic targets in acute ischemic diseases.
@en
P2093
P1476
microRNA: emerging therapeutic targets in acute ischemic diseases.
@en
P2093
Fabio Martelli
Maurizio C Capogrossi
Mircea Ivan
Pasquale Fasanaro
Simona Greco
P304
P356
10.1016/J.PHARMTHERA.2009.10.003
P577
2009-11-06T00:00:00Z